Medicare Expands Coverage of Drugs for Cancer Treatment
Medicare has expanded its coverage of off-label use of some medications to treat cancer. Doctors had pushed for the changes, arguing that such treatments are critical to providing patients with the most up-to-date care. However, opponents of the move argue that the new approach might waste money and expose patients to side effects of drugs that might not help them.
- "Medicare Widens Drugs It Accepts for Cancer Care" (Abelson/Pollack, New York Times, 1/27).